Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 164

recruiting
3 974
countries
28
conditions
2 109

10 386 trials match your criteria

Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
Countries:FranceFrance
  • Participants:0–17 years

Study on Stopping Nivolumab or Pembrolizumab in Advanced Melanoma Patients After Achieving a Response

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years

Trisomy 21

Recruiting

Study on Bumetanide for Improving Cognitive Function in Children and Adolescents with Down Syndrome

Registered drug
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Bumetanide

Study of Arfolitixorin, 5-Fluorouracil, Oxaliplatin, and Bevacizumab for Patients with Metastatic Colorectal Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Arfolitixorin

Obesity

Recruiting

Study on the Effects of Cholecalciferol and Glycerol on Inflammation in Obese Elderly Patients with Vitamin D Deficiency

Registered drug
Countries:ItalyItaly
  • Participants:65+ years

Study Comparing Intrathecal Morphine and TAP Block with Ropivacaine and Clonidine for Pain Relief in Patients Undergoing Elective Cesarean Section

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Ropivacaine Hydrochloride

Study on the Effects of Tumor Removal in Patients with Metastatic Kidney Cancer Treated with Nivolumab and Ipilimumab Combination

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Axitinib

Study of PF-06821497 and Enzalutamide for Men with Advanced Prostate Cancer Resistant to Hormone Therapy

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:5,8-Dichloro-2-[(4-Methoxy-6-Methyl-2-Oxo-1,2-Dihydropyridin-3-Yl)Methyl]-7-[(R)-Methoxy(Oxetan-3-Yl)Methyl]-3,4-Dihydroisoquinolin-1(2H)-One

Colon cancer

Recruiting

Study of Dostarlimab for Patients with Untreated Stage III Resectable Colon Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years

Study on the Safety of Rotigotine for Patients with Autosomal Dominant Polycystic Kidney Disease

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.